|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:KDM6A-NDUFB11 (FusionGDB2 ID:41716) |
Fusion Gene Summary for KDM6A-NDUFB11 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: KDM6A-NDUFB11 | Fusion gene ID: 41716 | Hgene | Tgene | Gene symbol | KDM6A | NDUFB11 | Gene ID | 7403 | 54539 |
| Gene name | lysine demethylase 6A | NADH:ubiquinone oxidoreductase subunit B11 | |
| Synonyms | KABUK2|UTX|bA386N14.2 | CI-ESSS|ESSS|MC1DN30|NP17.3|Np15|P17.3 | |
| Cytomap | Xp11.3 | Xp11.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | lysine-specific demethylase 6AbA386N14.2 (ubiquitously transcribed X chromosome tetratricopeptide repeat protein (UTX))histone demethylase UTXlysine (K)-specific demethylase 6Aubiquitously transcribed tetratricopeptide repeat protein X-linkedubiquito | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrialNADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDaNADH-ubiquinone oxidoreductase ESSS subunitcomplex I NP17.3 subunitcomplex I-ESSSneuronal protein 17.3 | |
| Modification date | 20200313 | 20200328 | |
| UniProtAcc | O15550 | Q9NX14 | |
| Ensembl transtripts involved in fusion gene | ENST00000377967, ENST00000382899, ENST00000536777, ENST00000543216, ENST00000479423, | ENST00000377811, ENST00000276062, | |
| Fusion gene scores | * DoF score | 19 X 9 X 11=1881 | 3 X 3 X 2=18 |
| # samples | 20 | 3 | |
| ** MAII score | log2(20/1881*10)=-3.23342794374847 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: KDM6A [Title/Abstract] AND NDUFB11 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | KDM6A(44733233)-NDUFB11(47002143), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across KDM6A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across NDUFB11 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-AC-A2QJ-01A | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
Top |
Fusion Gene ORF analysis for KDM6A-NDUFB11 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000377967 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000377967 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000382899 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000382899 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000536777 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000536777 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000543216 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| In-frame | ENST00000543216 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| intron-3CDS | ENST00000479423 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| intron-3CDS | ENST00000479423 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000377967 | KDM6A | chrX | 44733233 | + | ENST00000377811 | NDUFB11 | chrX | 47002143 | - | 622 | 266 | 41 | 520 | 159 |
| ENST00000377967 | KDM6A | chrX | 44733233 | + | ENST00000276062 | NDUFB11 | chrX | 47002143 | - | 648 | 266 | 41 | 550 | 169 |
| ENST00000382899 | KDM6A | chrX | 44733233 | + | ENST00000377811 | NDUFB11 | chrX | 47002143 | - | 598 | 242 | 17 | 496 | 159 |
| ENST00000382899 | KDM6A | chrX | 44733233 | + | ENST00000276062 | NDUFB11 | chrX | 47002143 | - | 624 | 242 | 17 | 526 | 169 |
| ENST00000536777 | KDM6A | chrX | 44733233 | + | ENST00000377811 | NDUFB11 | chrX | 47002143 | - | 598 | 242 | 17 | 496 | 159 |
| ENST00000536777 | KDM6A | chrX | 44733233 | + | ENST00000276062 | NDUFB11 | chrX | 47002143 | - | 624 | 242 | 17 | 526 | 169 |
| ENST00000543216 | KDM6A | chrX | 44733233 | + | ENST00000377811 | NDUFB11 | chrX | 47002143 | - | 581 | 225 | 0 | 479 | 159 |
| ENST00000543216 | KDM6A | chrX | 44733233 | + | ENST00000276062 | NDUFB11 | chrX | 47002143 | - | 607 | 225 | 0 | 509 | 169 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000377967 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.005633528 | 0.99436647 |
| ENST00000377967 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.008609315 | 0.9913907 |
| ENST00000382899 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.005791825 | 0.9942082 |
| ENST00000382899 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.009859869 | 0.99014014 |
| ENST00000536777 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.005791825 | 0.9942082 |
| ENST00000536777 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.009859869 | 0.99014014 |
| ENST00000543216 | ENST00000377811 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.004845445 | 0.9951546 |
| ENST00000543216 | ENST00000276062 | KDM6A | chrX | 44733233 | + | NDUFB11 | chrX | 47002143 | - | 0.009004407 | 0.9909956 |
Top |
Fusion Genomic Features for KDM6A-NDUFB11 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for KDM6A-NDUFB11 |
| Go to FGviewer for the breakpoints of chrX:44733233-chrX:47002143 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| KDM6A | NDUFB11 |
| FUNCTION: Histone demethylase that specifically demethylates 'Lys-27' of histone H3, thereby playing a central role in histone code (PubMed:17851529, PubMed:17713478, PubMed:17761849). Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-27' (PubMed:17851529, PubMed:17713478, PubMed:17761849). Plays a central role in regulation of posterior development, by regulating HOX gene expression (PubMed:17851529). Demethylation of 'Lys-27' of histone H3 is concomitant with methylation of 'Lys-4' of histone H3, and regulates the recruitment of the PRC1 complex and monoubiquitination of histone H2A (PubMed:17761849). Plays a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression (By similarity). {ECO:0000250|UniProtKB:O70546, ECO:0000269|PubMed:17713478, ECO:0000269|PubMed:17761849, ECO:0000269|PubMed:17851529, ECO:0000269|PubMed:18003914}. | FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 9_17 | 75.0 | 1402.0 | Compositional bias | Note=Poly-Ala |
| Tgene | NDUFB11 | chrX:44733233 | chrX:47002143 | ENST00000276062 | 0 | 3 | 89_109 | 69.0 | 164.0 | Transmembrane | Helical | |
| Tgene | NDUFB11 | chrX:44733233 | chrX:47002143 | ENST00000377811 | 0 | 3 | 89_109 | 69.0 | 154.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 1095_1258 | 75.0 | 1402.0 | Domain | JmjC |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 130_163 | 75.0 | 1402.0 | Repeat | Note=TPR 2 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 170_199 | 75.0 | 1402.0 | Repeat | Note=TPR 3 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 205_238 | 75.0 | 1402.0 | Repeat | Note=TPR 4 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 250_283 | 75.0 | 1402.0 | Repeat | Note=TPR 5 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 284_317 | 75.0 | 1402.0 | Repeat | Note=TPR 6 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 318_351 | 75.0 | 1402.0 | Repeat | Note=TPR 7 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 352_385 | 75.0 | 1402.0 | Repeat | Note=TPR 8 |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 93_126 | 75.0 | 1402.0 | Repeat | Note=TPR 1 |
Top |
Fusion Gene Sequence for KDM6A-NDUFB11 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000377967_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=622nt_BP=266nt GGGGGGTGTCGGCGTTGGAGTTGTGAATTCGCTGCGTTTCCATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCG CTTTCGGTGATGAGGAAAAGAAAATGGCGGCGGGAAAAGCGAGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGG AGGCGCTCGGCGGACTGGACAGCCGCCTCTTTGGGTTCGTGAGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACC CAGACTCCCATGGTTATGACAAGGACCCCGTTTTGGACGTCTGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCC TTGGCAGCACCTTTGTGGCCTATCTGCCTGACTACAGGATGAAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACCGAGAGG CCAATGGCCTTCCCATCATGGAATCCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGTGGGGCT >In-frame_ENST00000377967_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=159AA_start in transcript=41_stop in transcript=520 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000377967_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=648nt_BP=266nt GGGGGGTGTCGGCGTTGGAGTTGTGAATTCGCTGCGTTTCCATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCG CTTTCGGTGATGAGGAAAAGAAAATGGCGGCGGGAAAAGCGAGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGG AGGCGCTCGGCGGACTGGACAGCCGCCTCTTTGGGTTCGTGAGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACC CAGACTCCCATGGTTATGACAAGGACCCCGTTTTGGACGTCTGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCC TTGGCAGCACCTTTGTGGCCTATCTGCCTGACTACAGGTGCACAGGGTGTCCAAGAGCGTGGGATGGGATGAAAGAGTGGTCCCGCCGCG AAGCTGAGAGGCTTGTGAAATACCGAGAGGCCAATGGCCTTCCCATCATGGAATCCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAG AGGATGAGTGACCAGTTGCTAAGTGGGGCTCAAGAAGCACCGCCTTCCCCACCCCCTGCCTGCCATTCTGACCTCTTCTCAGAGCACCTA >In-frame_ENST00000377967_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=169AA_start in transcript=41_stop in transcript=550 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000382899_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=598nt_BP=242nt GAATTCGCTGCGTTTCCATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCGCTTTCGGTGATGAGGAAAAGAAAA TGGCGGCGGGAAAAGCGAGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGGAGGCGCTCGGCGGACTGGACAGCC GCCTCTTTGGGTTCGTGAGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACCCAGACTCCCATGGTTATGACAAGG ACCCCGTTTTGGACGTCTGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCCTTGGCAGCACCTTTGTGGCCTATC TGCCTGACTACAGGATGAAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACCGAGAGGCCAATGGCCTTCCCATCATGGAAT CCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGTGGGGCTCAAGAAGCACCGCCTTCCCCACCC >In-frame_ENST00000382899_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=159AA_start in transcript=17_stop in transcript=496 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000382899_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=624nt_BP=242nt GAATTCGCTGCGTTTCCATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCGCTTTCGGTGATGAGGAAAAGAAAA TGGCGGCGGGAAAAGCGAGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGGAGGCGCTCGGCGGACTGGACAGCC GCCTCTTTGGGTTCGTGAGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACCCAGACTCCCATGGTTATGACAAGG ACCCCGTTTTGGACGTCTGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCCTTGGCAGCACCTTTGTGGCCTATC TGCCTGACTACAGGTGCACAGGGTGTCCAAGAGCGTGGGATGGGATGAAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACC GAGAGGCCAATGGCCTTCCCATCATGGAATCCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGT >In-frame_ENST00000382899_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=169AA_start in transcript=17_stop in transcript=526 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000536777_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=598nt_BP=242nt GAATTCGCTGCGTTTCCATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCGCTTTCGGTGATGAGGAAAAGAAAA TGGCGGCGGGAAAAGCGAGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGGAGGCGCTCGGCGGACTGGACAGCC GCCTCTTTGGGTTCGTGAGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACCCAGACTCCCATGGTTATGACAAGG ACCCCGTTTTGGACGTCTGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCCTTGGCAGCACCTTTGTGGCCTATC TGCCTGACTACAGGATGAAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACCGAGAGGCCAATGGCCTTCCCATCATGGAAT CCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGTGGGGCTCAAGAAGCACCGCCTTCCCCACCC >In-frame_ENST00000536777_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=159AA_start in transcript=17_stop in transcript=496 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000536777_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=624nt_BP=242nt GAATTCGCTGCGTTTCCATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCGCTTTCGGTGATGAGGAAAAGAAAA TGGCGGCGGGAAAAGCGAGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGGAGGCGCTCGGCGGACTGGACAGCC GCCTCTTTGGGTTCGTGAGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACCCAGACTCCCATGGTTATGACAAGG ACCCCGTTTTGGACGTCTGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCCTTGGCAGCACCTTTGTGGCCTATC TGCCTGACTACAGGTGCACAGGGTGTCCAAGAGCGTGGGATGGGATGAAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACC GAGAGGCCAATGGCCTTCCCATCATGGAATCCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGT >In-frame_ENST00000536777_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=169AA_start in transcript=17_stop in transcript=526 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000543216_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=581nt_BP=225nt ATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCGCTTTCGGTGATGAGGAAAAGAAAATGGCGGCGGGAAAAGCG AGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGGAGGCGCTCGGCGGACTGGACAGCCGCCTCTTTGGGTTCGTG AGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACCCAGACTCCCATGGTTATGACAAGGACCCCGTTTTGGACGTC TGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCCTTGGCAGCACCTTTGTGGCCTATCTGCCTGACTACAGGATG AAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACCGAGAGGCCAATGGCCTTCCCATCATGGAATCCAACTGCTTCGACCCC AGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGTGGGGCTCAAGAAGCACCGCCTTCCCCACCCCCTGCCTGCCATTCTGA >In-frame_ENST00000543216_ENST00000377811_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=159AA_start in transcript=0_stop in transcript=479 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- >In-frame_ENST00000543216_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(transcript)=607nt_BP=225nt ATGAAATCCTGCGGAGTGTCGCTCGCTACCGCCGCCGCTGCCGCCGCCGCTTTCGGTGATGAGGAAAAGAAAATGGCGGCGGGAAAAGCG AGCGGCGAGAGCGAGGAGGCGTCCCCCAGCCTGACAGCCGAGGAGAGGGAGGCGCTCGGCGGACTGGACAGCCGCCTCTTTGGGTTCGTG AGATTTCATGAAGATGGCGCCAGGACGAAGGCCCTACTGGGCAAGAACCCAGACTCCCATGGTTATGACAAGGACCCCGTTTTGGACGTC TGGAACATGCGACTTGTCTTCTTCTTTGGCGTCTCCATCATCCTGGTCCTTGGCAGCACCTTTGTGGCCTATCTGCCTGACTACAGGTGC ACAGGGTGTCCAAGAGCGTGGGATGGGATGAAAGAGTGGTCCCGCCGCGAAGCTGAGAGGCTTGTGAAATACCGAGAGGCCAATGGCCTT CCCATCATGGAATCCAACTGCTTCGACCCCAGCAAGATCCAGCTGCCAGAGGATGAGTGACCAGTTGCTAAGTGGGGCTCAAGAAGCACC >In-frame_ENST00000543216_ENST00000276062_TCGA-AC-A2QJ-01A_KDM6A_chrX_44733233_+_NDUFB11_chrX_47002143_length(amino acids)=169AA_start in transcript=0_stop in transcript=509 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFVRFHEDGARTKALLGKNPDSHGYDKDPVLDV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for KDM6A-NDUFB11 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | KDM6A | chrX:44733233 | chrX:47002143 | ENST00000377967 | + | 2 | 29 | 1_1095 | 75.0 | 1402.0 | SUPT6H |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for KDM6A-NDUFB11 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for KDM6A-NDUFB11 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | KDM6A | C3275495 | KABUKI SYNDROME 2 | 5 | GENOMICS_ENGLAND |
| Hgene | KDM6A | C0005684 | Malignant neoplasm of urinary bladder | 1 | CGI;CTD_human |
| Hgene | KDM6A | C0005695 | Bladder Neoplasm | 1 | CGI;CTD_human |
| Hgene | KDM6A | C0006826 | Malignant Neoplasms | 1 | CGI;CTD_human |
| Hgene | KDM6A | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
| Hgene | KDM6A | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | KDM6A | C0027651 | Neoplasms | 1 | CTD_human |
| Hgene | KDM6A | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | KDM6A | C0086692 | Benign Neoplasm | 1 | CTD_human |
| Hgene | KDM6A | C0279626 | Squamous cell carcinoma of esophagus | 1 | CGI;CTD_human |
| Hgene | KDM6A | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Hgene | KDM6A | C0796004 | Kabuki make-up syndrome | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Tgene | NDUFB11 | C0796070 | MICROPHTHALMIA, SYNDROMIC 7 | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Tgene | NDUFB11 | C1838979 | MITOCHONDRIAL COMPLEX I DEFICIENCY | 1 | ORPHANET |
| Tgene | NDUFB11 | C4225421 | LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3 | 1 | CTD_human;GENOMICS_ENGLAND |
| Tgene | NDUFB11 | C4746985 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30 | 1 | GENOMICS_ENGLAND;UNIPROT |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies